Written resources

Listed below are our written resources.

 Indicates a resource containing technical content written for a health professional audience.

Most of these resources are PDF files.  Click the Adobe Reader image to visit the Adobe website and download the free PDF file viewer software  .

To search for a particular written resource, use the search box below. 

Concerns and questions

  • Aluminium in vaccines Factsheet (121.83 KB)
  • The facts about childhood vaccines Factsheet (345.96 KB)
  • Thimerosal: What you should know Factsheet (192.65 KB)
  • Vaccine ingredients Factsheet (302.26 KB)
  • Adverse events following immunisation

  • Anaphylaxis and vaccination Factsheet (271.21 KB)
  • Health Professionals
  • Hyperventilation Factsheet (244.94 KB)
  • Health Professionals

    Cold chain

    Health Professionals

    A clinic based quality tool to support you in maintaining high cold chain standards. The guide enables providers to have instant access to temperature-recording charts at the refrigerator site, use the trouble shooting tips for cold chain problems, have a self audit tool to check your clinic is on target for excellence, keep track of your clinic’s cold chain history and use for orientation of new staff.

  • Cold Chain Policy Template 2013 Forms/Schedules (271.5 KB)
  • Health Professionals

    This template provides the information required to assist immunisation providers to develop their own cold chain management policy.

    Health Professionals

    The Guidelines have been produced on behalf of the Ministry of Health and serve as an interim measure for District Health Boards and other immunisation providers to help with the purchase of chilly bins for off-site immunisation services. They were developed following a limited literature review and should be used in conjunction with the National Guidelines for Vaccine Storage and Distribution 2012 (Ministry of Health) that is under review. This review is expected to take most of 2016, further advice on purchasing chilly bins will not be available until the review is complete.

    Health Professionals

    A pictorial guide for reading the TagAlert® and recording the information and answers to frequent questions about this change to the National Cold-chain Audit. Updated March 2014.

    Health Professionals

    These guidelines are for practices to ensure that vaccines delivered within New Zealand have been stored correctly to maximise their effectiveness. These guidelines supercede the Vaccine Storage and Distribution National Standards 2002 and supplement the cold chain policy in the Immunisation Handbook 2011.

  • The essential cold chain Factsheet (246.26 KB)
  • Health Professionals

    This fact sheet summarises the most important requirements for maintenance of the vaccine cold chain.

  • The essential data logger Factsheet (133.96 KB)
  • Health Professionals

    This fact sheet provides an introduction to the use of data loggers to ensure optimal cold chain maintenance.

  • Vaccine Register Forms/Schedules (304 KB)
  • Health Professionals

    A template for an easy to use Vaccine Register.

    Ministry of Health faxes

    Reports about immunisation

    In 2009 the Institute of Medicine was tasked, by the Health Resources and Services Administration in the U.S., to convene a committee of experts to review the epidemiologic, clinical, and biological evidence regarding adverse health events associated with specific vaccines including varicella zoster vaccine; influenza vaccines; hepatitis B vaccine; human papillomavirus vaccine (HPV); tetanus toxoid-containing vaccines other than those containing the whole cell pertussis component; measles, mumps, and rubella vaccines; hepatitis A vaccine; and meningococcal vaccines. The focus was only on the assessment of risk of vaccines. The prepublication copy: uncorrected proof is available on line. (Institute of Medicine of the National Academies, 25 August 2011)

    Following on from the Adverse effects of vaccines: Evidence and causality report, the Institute of Medicine was tasked, by the Department of Health and Human Services in the U.S., to convene a committee of experts to identify scientific findings and stakeholder concerns about the safety of the current U.S. childhood immunisation schedule and identify research approaches, methodologies, and study designs that could inform this question. The prepublication copy: uncorrected proof is available on line. (Institute of Medicine of the National Academies, 16 January 2013)

    Prepared by the Health Quality & Safety Commission for the Child and Youth Mortality Review Committee, the report emphasises the need for existing immunisation programmes to reduce the risk of pertussis in infants, especially those who are Maori, Pacific or under 3 months of age. The report also establishes the need for strategies to raise awareness of the maternal Tdap immunisation in the third trimester and to improve access to and timely administration of the first three infant immunisation events, particularly for Maori and Pacific infants for whom significant equity issues were identified.

    Health Professionals

    The recommendations of this report, written by Tim Corbett and funded by GlaxoSmithKline, are aimed at increasing the level of comfort whānau experience in General Practice through proactive, whānau based communication and service enhancement approaches.